Schering-Plough wins US dismissal of Intron A/Temodar off-label suit
28 July 2009
Nancy Faigen
Please Login to read the full article.
28 July 2009
Nancy Faigen
A US federal court has dismissed a class action lawsuit that alleged Schering-Plough had illegally marketed Intron A (interferon alfa-2b) and Temodar (temozolomide) for off-label use.
The plaintiffs were in part claiming fraud under the Racketeer Influenced and Corrupt Organizations...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
- Supreme Court rules against statistically significant 'bright-line' rule in Matrixx
- J&J to pay $158M to settle Texas Medicaid fraud case
- Ukraine may open criminal investigation into former prime minister's role in vaccines scam
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
